TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27409603

Group type: EXPERIMENTAL
Intervention: Sarcosine (2 grams daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 27429285

Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT PICO™ dressing)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard care (Comfeel Plus(®) dressing)
Number of subjects: 92
Study: 22828288

Group type: EXPERIMENTAL
Intervention: Integrated PCST and exercise program delivered by physiotherapists
Number of subjects: 3

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 3

Group type: COMPARATOR
Intervention: PCST alone
Number of subjects: 3
Study: 20428367

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aquaphor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 18686773

Group type: EXPERIMENTAL
Intervention: Stannous fluoride/sodium hexametaphosphate dentifrice
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cetylpyridinium chloride mouthrinse with stannous fluoride dentifrice
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sodium fluoride triclosan/copolymer dentifrice
Number of subjects: 16

Group type: COMPARATOR
Intervention: Essential oil mouthrinse with triclosan dentifrice
Number of subjects: 16
Study: 16572647

Group type: EXPERIMENTAL
Intervention: Surgery with neuronavigation (SN)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Standard surgery (SS)
Number of subjects: 45
Study: 12960179

Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) injection
Number of subjects: 16
Study: 10687883

Group type: EXPERIMENTAL
Intervention: Menorest (50 microg/24 h)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Climara (50 microg/24 h)
Number of subjects: 20
Study: 9431499

Group type: EXPERIMENTAL
Intervention: Written condition (transcription of pediatrician's instructions)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Oral condition (verbal instruction only)
Number of subjects: 96
Study: 10135639

Group type: EXPERIMENTAL
Intervention: Interactive statistical package (ISP) using pretreatment clinical factors (PSA, Gleason score, clinical stage, MRI findings)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Interactive statistical package (ISP)
Number of subjects: 174
Study: 3531113

Group type: EXPERIMENTAL
Intervention: Combination of misonidazole (2.0 gm/m2) and hyperbaric oxygen (3 ATA) with irradiation (6.0 Gy in 30 fractions)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional irradiation (63.00 Gy in 30 fractions)
Number of subjects: 130
Study: 31097299

Group type: EXPERIMENTAL
Intervention: Four-week trunk-specific rehabilitation program (active self-correction exercises, passive and active trunk stabilization exercises, functional tasks)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Four-week trunk-specific rehabilitation program
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (joint mobilization, muscle strengthening and stretching, gait and balance exercises)
Number of subjects: 37
Study: 29603684

Group type: EXPERIMENTAL
Intervention: Pemafibrate (0.4 mg/day, b.i.d.)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Pemafibrate
Number of subjects: 27
Study: 26735225

Group type: EXPERIMENTAL
Intervention: Chloroquine 150 mg once daily for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo once daily for 8 weeks
Number of subjects: 0
Study: 24698346

Group type: EXPERIMENTAL
Intervention: Retinol (7.5 mg RE/d)
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg/d)
Number of subjects: 998
Study: 23227789

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture coupled with conventional treatments
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional treatments alone
Number of subjects: 30
Study: 20682023

Group type: EXPERIMENTAL
Intervention: Counseling on diet, physical activity, and gestational weight gain during pregnancy (one session at 8-12 weeks for physical activity, one session at 16-18 weeks for diet, and three to four booster sessions during routine visits)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Counseling on diet and physical activity
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Blood samples for lipid status, hormones, insulin, and OGTT
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Questionnaire on workability and return to work
Number of subjects: 14
Study: 17638703

Group type: EXPERIMENTAL
Intervention: IPTi with sulfadoxine‐pyrimethamine
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study: 15450784

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) levels in RBC
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Highest quartile of EPA in RBC
Number of subjects: 200
Study: 11251010

Group type: EXPERIMENTAL
Intervention: 5‐FU plus leucovorin (arm A)
Number of subjects: 680

Group type: COMPARATOR
Intervention: 5‐FU plus levamisole (arm B)
Number of subjects: 680
Study: 9606226

Group type: EXPERIMENTAL
Intervention: Case management/home visitation intervention with at least four home visits during the infant's first year of life
Number of subjects: 365

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 365

Group type: EXPERIMENTAL
Intervention: Case management/home visitation intervention
Number of subjects: 365
Study: 8014723

Group type: EXPERIMENTAL
Intervention: ACI-TIPI intervention during experimental months
Number of subjects: 418

Group type: COMPARATOR
Intervention: Control group (no ACI-TIPI provided during control months)
Number of subjects: 418
Study: 2499185

Group type: EXPERIMENTAL
Intervention: Water (0 mOsm/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mannitol solution (142 mOsm/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mannitol solution (296 mOsm/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mannitol solution (449 mOsm/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mannitol solution (704 mOsm/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Mannitol solution (1481 mOsm/kg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Orange juice (585 mOsm/kg)
Number of subjects: 10
Study: 31418621

Group type: COMPARATOR
Intervention: Topical cantharidin (control group A)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intralesional tuberculin PPD (group B)
Number of subjects: 40
Study: 30707135

Group type: EXPERIMENTAL
Intervention: Breakfast consumption (BC)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Breakfast omission (BO)
Number of subjects: 16
Study: 28976919

Group type: EXPERIMENTAL
Intervention: Wearable camera methodology (Kids’Cam Tonga)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Improvements to housing stock
Number of subjects: 72
Study: 26501503

Group type: EXPERIMENTAL
Intervention: Detailed procedural instructions with principles studied before training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: General procedural instructions
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Detailed procedural instructions
Number of subjects: 24
Study: 24242024

Group type: EXPERIMENTAL
Intervention: Modified busulfan-fludarabine (mBuF) regimen
Number of subjects: 105

Group type: COMPARATOR
Intervention: Modified busulfan-cyclophosphamide (mBuCy) regimen
Number of subjects: 105
Study: 21164305

Group type: EXPERIMENTAL
Intervention: Operative group (n = 45)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Nonoperative group (n = 28)
Number of subjects: 73
Study: 19915681

Group type: EXPERIMENTAL
Intervention: Cisplatin and etoposide (PE) regimen
Number of subjects: 10262

Group type: EXPERIMENTAL
Intervention: Cisplatin-based regimens
Number of subjects: 10262

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation
Number of subjects: 10262

Group type: EXPERIMENTAL
Intervention: Good performance status (PS)
Number of subjects: 10262

Group type: COMPARATOR
Intervention: Cyclophosphamide, doxorubicin, and vincristine-based regimens
Number of subjects: 10262
Study: 16409331

Group type: EXPERIMENTAL
Intervention: NiTi-TEE
Number of subjects: 50

Group type: COMPARATOR
Intervention: K3
Number of subjects: 50
Study: 15064661

Group type: EXPERIMENTAL
Intervention: NormLoudn
Number of subjects: 21

Group type: COMPARATOR
Intervention: LessLoudn
Number of subjects: 21

Group type: COMPARATOR
Intervention: Speech recognition scores for NormLoudn
Number of subjects: 21

Group type: COMPARATOR
Intervention: Speech recognition scores for LessLoudn
Number of subjects: 21
Study: 11171788

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 121

Group type: COMPARATOR
Intervention: Captopril
Number of subjects: 121
Study: 9230237

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 31
Study: 8480272

Group type: EXPERIMENTAL
Intervention: 0.5 gram of prophylactic imipenem administered intravenously every eight hours for two weeks
Number of subjects: 74

Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 74
Study: 2887081

Group type: EXPERIMENTAL
Intervention: Primidone (62.5 mg X 1 up to 250 mg X 3 daily)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Propranolol (20 mg X 3 daily)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Primidone
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo and Propranolol
Number of subjects: 13
Study: 30378129

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection
Number of subjects: 47

Group type: COMPARATOR
Intervention: Blind injection
Number of subjects: 47
Study: 27974307

Group type: EXPERIMENTAL
Intervention: Modified hospital menu with higher energy options
Number of subjects: 122

Group type: COMPARATOR
Intervention: Standard menu
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study: 26130302

Group type: EXPERIMENTAL
Intervention: 2% whey protein-enriched water (178 kJ)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4% whey protein-enriched water (348 kJ)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2% sucrose-enriched water (157 kJ)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4% sucrose-enriched water (314 kJ)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10% sucrose-enriched water (785 kJ)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sweetened water control
Number of subjects: 60
Study: 23804631

Group type: EXPERIMENTAL
Intervention: Asunaprevir 200 mg twice daily + PEG-IFN + ribavirin
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Asunaprevir 600 mg twice daily + PEG-IFN + ribavirin
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Asunaprevir 600 mg once daily + PEG-IFN + ribavirin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo + PEG-IFN + ribavirin
Number of subjects: 47
Study: 21668321

Group type: EXPERIMENTAL
Intervention: Breathing retraining (12 individual sessions)
Number of subjects: 40
Study: 18769963

Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day for 3 years)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 16790627

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg initial dose followed by continuous infusion of 0.5 microg.kg(‐1).h(‐1))
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol (3 mg/kg initial dose followed by continuous infusion of 100 microg.kg(‐1).min(‐1))
Number of subjects: 60
Study: 12923821

Group type: EXPERIMENTAL
Intervention: DA agonist (lisuride=LIS)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: DA antagonist (fluphenazine=FLU)
Number of subjects: 36

Group type: COMPARATOR
Intervention: High basal cortisol levels
Number of subjects: 36

Group type: COMPARATOR
Intervention: Low basal cortisol levels
Number of subjects: 36
Study: 12696319

Group type: EXPERIMENTAL
Intervention: Trapezoidal classroom shape
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional rectangular classroom shape
Number of subjects: 0
Study: 9287629

Group type: EXPERIMENTAL
Intervention: Teaching hardiness
Number of subjects: 0
Study: 8463932

Group type: EXPERIMENTAL
Intervention: Stress Management Training (SMT)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard outpatient treatment (Control)
Number of subjects: 19
Study: 3517475

Group type: EXPERIMENTAL
Intervention: BAY m 1099 (25, 50, 100, 200 mg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: BAY o 1248 (10, 20, 40 mg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 29194765

Group type: EXPERIMENTAL
Intervention: Toceranib (TOC) 2.75 mg/kg EOD
Number of subjects: 88

Group type: COMPARATOR
Intervention: Vinblastine (VBL) 2.5 mg/m2 weekly × 4 then EOW
Number of subjects: 88
Study: 27559981

Group type: EXPERIMENTAL
Intervention: Laser acupuncture
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control
Number of subjects: 66
Study: 24836151

Group type: EXPERIMENTAL
Intervention: Antisocial in-group member
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prosocial out-group member
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control agents (moral information removed)
Number of subjects: 0
Study: 22569079

Group type: EXPERIMENTAL
Intervention: Water immersion insertion and CO2 insufflation (water/CO2)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Water insertion and air insufflation (water/air)
Number of subjects: 404

Group type: COMPARATOR
Intervention: CO2 insufflation during both insertion and withdrawal (CO2/CO2)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Air insufflation during both insertion and withdrawal (air/air)
Number of subjects: 404
Study: 20393740

Group type: EXPERIMENTAL
Intervention: Alternation flicker technology
Number of subjects: 68

Group type: COMPARATOR
Intervention: Digital photography inspection
Number of subjects: 68
Study: 19146152

Group type: EXPERIMENTAL
Intervention: Tuigua manipulation combined with quadriceps exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Manipulation for osteoarthritis in Tuina Xue (Control)
Number of subjects: 48
Study: 15824212

Group type: EXPERIMENTAL
Intervention: Simvastatin (80 mg/d)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12625145

Group type: EXPERIMENTAL
Intervention: Simultaneous dosing (artesunate 200 mg/d plus mefloquine 250 mg/d from day 1 to day 3)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sequential dosing (artesunate 200 mg/d for 3 days plus mefloquine 250 mg on day 2 and 500 mg on day 3)
Number of subjects: 104
Study: 12412178

Group type: EXPERIMENTAL
Intervention: Morphine mouthwash (MO; 14 patients)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Magic mouthwash (MG; 12 patients)
Number of subjects: 26
Study: 9589525

Group type: EXPERIMENTAL
Intervention: Spinal cord injury (SCI)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: Traumatic brain injury (TBI)
Number of subjects: 453

Group type: COMPARATOR
Intervention: General population (controls)
Number of subjects: 453
Study: 8029260

Group type: EXPERIMENTAL
Intervention: High-dose human leukocyte alpha-interferon (IFN-alpha) treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 2929931

Group type: EXPERIMENTAL
Intervention: Topical application of 2% lignocaine
Number of subjects: 0
Study: 31155869

Group type: EXPERIMENTAL
Intervention: Moxibustion therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Manual acupuncture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (Moxibustion and Acupuncture)
Number of subjects: 60
Study: 28333939

Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg slow-release three times daily
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 109
Study: 25813692

Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 438

Group type: COMPARATOR
Intervention: non-MRI
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: MRI (cT1 subgroup)
Number of subjects: 438

Group type: COMPARATOR
Intervention: non-MRI (cT1 subgroup)
Number of subjects: 438
Study: 23459753

Group type: EXPERIMENTAL
Intervention: 4 × 20 g whey protein every 3 h (INT)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 8 × 10 g whey protein every 1.5 h (PULSE)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 2 × 40 g whey protein every 6 h (BOLUS)
Number of subjects: 24
Study: 20809354

Group type: EXPERIMENTAL
Intervention: Telephone administered cognitive behavioral therapy
Number of subjects: 127

Group type: COMPARATOR
Intervention: Telephone administered supportive emotion‐focused therapy
Number of subjects: 127
Study: 19356666

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using 'Photogem'
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Photosens
Number of subjects: 72

Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 72
Study: 17123204

Group type: EXPERIMENTAL
Intervention: MIME robotic device (bilateral, unilateral, and combined bilateral and unilateral training)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined unilateral and bilateral robotic training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Robot-assisted treatment (all types)
Number of subjects: 0
Study: 12827582

Group type: EXPERIMENTAL
Intervention: Alfentanil 10 micro g/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Remifentanil 1 micro g/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Remifentanil 2 micro g/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 80
Study: 10747343

Group type: EXPERIMENTAL
Intervention: Carvedilol (25 mg twice daily for 5 months)
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 406
Study: 9373227

Group type: EXPERIMENTAL
Intervention: Early enteral feeding by nasojejunal tube
Number of subjects: 29

Group type: COMPARATOR
Intervention: Parenteral nutrition by central venous catheter
Number of subjects: 29
Study: 1539787

Group type: EXPERIMENTAL
Intervention: Oral airways
Number of subjects: 36

Group type: COMPARATOR
Intervention: Nasopharyngeal airways
Number of subjects: 36
Study: 29461674

Group type: COMPARATOR
Intervention: Balanced salt solution (BSS)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Air-tamponade
Number of subjects: 69
Study: 30634209

Group type: EXPERIMENTAL
Intervention: Whole CDBBES recipe (containing leeches and equivalent insects)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CDBBES recipe (removing leech and gradfly)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study: 24667813

Group type: EXPERIMENTAL
Intervention: VACS Index
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Restricted Index
Number of subjects: 324
Study: 21971750

Group type: EXPERIMENTAL
Intervention: BTX‐A (Xeomin) injected into the deep and superficial finger (100 units) and wrist flexors (50 units)
Number of subjects: 18

Group type: COMPARATOR
Intervention: No injection (Control group)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: BTX‐A (Xeomin)
Number of subjects: 18
Study: 19940853

Group type: EXPERIMENTAL
Intervention: CPAP therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 40
Study: 18474534

Group type: EXPERIMENTAL
Intervention: Early Gp IIb-IIIa inhibitors
Number of subjects: 1662

Group type: EXPERIMENTAL
Intervention: Early abciximab
Number of subjects: 1662
Study: 15983677

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) 1.5 million units
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) 2.5 million units
Number of subjects: 50
Study: 11794455

Group type: EXPERIMENTAL
Intervention: 100% oxygen at 10 L/min through a facemask
Number of subjects: 100

Group type: COMPARATOR
Intervention: Air
Number of subjects: 100
Study: 10524419

Group type: EXPERIMENTAL
Intervention: Hyperfractionation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional fractionation
Number of subjects: 30
Study: 7739097

Group type: EXPERIMENTAL
Intervention: Sevoflurane anesthesia (end‐tidal concentration 4.5%)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Halothane anesthesia (end‐tidal concentration 1.6%)
Number of subjects: 106
Study: 1791060

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine (5 and 10 mg orally, 1 hr prior to test)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Yogic meditation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo (lactose capsule)
Number of subjects: 3
Study: 6808820

Group type: EXPERIMENTAL
Intervention: Encainide
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30919735

Group type: EXPERIMENTAL
Intervention: Electrical stimulation with the Veinplicity® device followed by a tourniquet (intervention group 2)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Electrical stimulation without a tourniquet (intervention group 1)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Tourniquet only (control group)
Number of subjects: 141
Study: 29458902

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control group (no LNG-IUS)
Number of subjects: 133
Study: 26864728

Group type: EXPERIMENTAL
Intervention: Prehabilitation (4-week supervised exercise programme, high-intensity cycle, interval training, 12 sessions)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 38
Study: 24866067

Group type: COMPARATOR
Intervention: Conventional scalpel
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Electrocautery
Number of subjects: 133
Study: 22116464

Group type: EXPERIMENTAL
Intervention: Trastuzumab plus capecitabine and cisplatin (HXP arm)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Capecitabine and cisplatin (XP arm)
Number of subjects: 22
Study: 19766038

Group type: EXPERIMENTAL
Intervention: Medical abortion at home
Number of subjects: 399

Group type: COMPARATOR
Intervention: Medical abortion at hospital
Number of subjects: 399
Study: 17891666

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 55

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 55
Study: 16279255

Group type: EXPERIMENTAL
Intervention: Covariate-based constrained randomization procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blocked and/or stratified designs
Number of subjects: 0
Study: 11592727

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (4.2 g/d)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Olive oil (control)
Number of subjects: 53